Regeneca Worldwide is expanding its voluntarily nationwide recall of RenegeSlim appetite control dietary supplement because FDA analysis confirmed the presence of DMAA. DMAA is 1,3-dimethylamylamind, methylhexanamine, or geranium extract. It can narrow blood vessels and arteries, which can cause a rise in blood pressure that increases the risk of heart attack. No illnesses have been reported to date.
RegeneSlim is purchased by and distributed through retail direct sales force in the United States and Puerto Rico, and through online sales. It is packaged in 3-1/2″ x 3″ green and white sachets that contain 2 capsules, with the name RegeneSlim displayed on the front. The recall is expanding to include lot #823230415, lot #EX0616r 15813, Lot # EX0616R15814 and Lot #11414re5516.
If you purchased this product, do not consume it. Return it to the place of purchase for a refund or exchange. Adverse reactions can be reported to the FDA’s MedWatch Adverse Event Reporting program.
